Neuronetics
STIM
74 hedge funds and large institutions have $53.6M invested in Neuronetics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 15 closing their positions.
1,967% more call options, than puts
Call options by funds: $62K | Put options by funds: $3K
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
0.56% more ownership
Funds ownership: 64.44% → 65% (+0.56%)
10% less funds holding
Funds holding: 82 → 74 (-8)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
55% less capital invested
Capital invested by funds: $119M → $53.6M (-$65.5M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.66M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.88M |
| 3 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$1.56M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.06M |
| 5 |
Renaissance Technologies
New York
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$2.08M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$2.06M |
| 3 |
Morgan Stanley
New York
|
-$1.44M |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$1.29M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$993K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$993K | -144,502 | Closed |
|
77
Envestnet Asset Management
Chicago,
Illinois
| – | -$877K | -127,680 | Closed |
|
78
Jane Street
New York
| – | -$389K | -56,602 | Closed |
|
79
Walleye Capital
New York
| – | -$229K | -33,379 | Closed |
|
|
OQS
80
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$192K | -27,892 | Closed |
|
81
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$168K | -24,454 | Closed |
|
|
JF
82
Jump Financial
Chicago,
Illinois
| – | -$155K | -22,605 | Closed |
|
|
SSA
83
Schonfeld Strategic Advisors
New York
| – | -$96.2K | -14,000 | Closed |
|
84
Man Group
London,
United Kingdom
| – | -$93.5K | -13,606 | Closed |
|
85
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$89K | -12,931 | Closed |
|
|
AWM
86
AE Wealth Management
Topeka,
Kansas
| – | -$87.9K | -12,796 | Closed |
|
87
Prudential Financial
Newark,
New Jersey
| – | -$85.2K | -12,400 | Closed |
|
|
PP
88
PDT Partners
New York
| – | -$74.5K | -10,850 | Closed |
|
|
FWA
89
Freedom Wealth Alliance
Brookfield,
Wisconsin
| – | -$15K | -2,185 | Closed |
|
STIM Hedge Fund Activity: Q1 2023 in Review
74 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q1 2023, worth a combined $53.6M — down 55% from $119M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of STIM and 7 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 26 added.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $4.66M. The largest seller was EAM Investors, exiting entirely with an estimated $2.08M sold.
- 74 institutional investors held Neuronetics (STIM) as of Q1 2023, down from 82 in Q4 2022.
- Funds reported $53.6M of Neuronetics stock for Q1 2023, down 55% quarter-over-quarter.
- 7 funds opened new Neuronetics positions in Q1 2023 and 15 closed out, a net change of -8 holders.
- The largest Neuronetics buyer in Q1 2023 was Balyasny Asset Management, an estimated $4.66M added.
- The largest Neuronetics seller in Q1 2023 was EAM Investors, an estimated $2.08M sold.
Based on aggregated 13F filings for Q1 2023.